Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows a revised version number (v3.5.4) replacing v3.5.3, indicating a deployment or patch without altering the displayed study information.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page footer updates the ClinicalTrials.gov release “Revision” number from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision metadata updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check95 days agoChange DetectedA new site revision label 'Revision: v3.4.2' was added. The old funding-status notice and the previous revision label 'Revision: v3.4.1' were removed.SummaryDifference0.4%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.